Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Multiple Sclerosis

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 9 articles:
HTML format
Text format



Single Articles


    December 2016
  1. MONTALBAN X, Hauser SL, Kappos L, Arnold DL, et al
    Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.
    N Engl J Med. 2016 Dec 21. doi: 10.1056/NEJMoa1606468.
    PubMed     Text format     Abstract available


  2. HAUSER SL, Bar-Or A, Comi G, Giovannoni G, et al
    Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
    N Engl J Med. 2016 Dec 21. doi: 10.1056/NEJMoa1601277.
    PubMed     Text format     Abstract available


  3. CALABRESI PA
    B-Cell Depletion - A Frontier in Monoclonal Antibodies for Multiple Sclerosis.
    N Engl J Med. 2016 Dec 21. doi: 10.1056/NEJMe1614717.
    PubMed     Text format    


    August 2016
  4. WEISFELD-ADAMS JD
    The Abyss.
    N Engl J Med. 2016;375:713-5.
    PubMed     Text format    


    April 2016
  5. PROBSTEL AK, Kuhle J, Lecourt AC, Vock I, et al
    Multiple Sclerosis and Antibodies against KIR4.1.
    N Engl J Med. 2016;374:1496-8.
    PubMed     Text format    


  6. CHASTRE A, Hafler DA, O'Connor KC
    Evaluation of KIR4.1 as an Immune Target in Multiple Sclerosis.
    N Engl J Med. 2016;374:1495-6.
    PubMed     Text format    


    November 2015
  7. MURRAY SG, Wachter RM, Cho KC, Dhaliwal G, et al
    CLINICAL PROBLEM-SOLVING. A Breakthrough Diagnosis.
    N Engl J Med. 2015;373:1865-70.
    PubMed     Text format    


    October 2015
  8. KAPPOS L, Wiendl H, Selmaj K, Arnold DL, et al
    Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
    N Engl J Med. 2015;373:1418-28.
    PubMed     Text format     Abstract available


    April 2015
  9. ROSENKRANZ T, Novas M, Terborg C
    PML in a patient with lymphocytopenia treated with dimethyl fumarate.
    N Engl J Med. 2015;372:1476-8.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: